Literature DB >> 1458942

Pediatric risk of mortality scoring overestimates severity of illness in infants.

J M Goddard1.   

Abstract

OBJECTIVE: To validate Pediatric Risk of Mortality (PRISM) scoring in infants and children admitted for intensive care.
DESIGN: Validation cohort.
SETTING: A five-bed pediatric ICU and three cots providing intensive care for surgical neonates, within a 159-bed tertiary care children's hospital. PATIENTS: All patients admitted for intensive care during an 18-month period, January 1990 to July 1991.
METHODS: Admission (first 24 hrs) PRISM scoring was introduced as a routine procedure. Discretion was allowed in requesting arterial blood gas measurements and clotting studies. All other parameters were intended to be measured on all patients.
MEASUREMENTS AND MAIN RESULTS: PRISM scores were obtained on 380 (88%) of 433 patients. Median age was 15 months. A complete PRISM score was obtained in 24% of cases and a score as intended (i.e., allowing discretionary omissions) was obtained in 56% of patients. Comparison of observed and predicted mortality rates using chi square goodness-of-fit tests showed a significantly better observed outcome for all patients (chi 2(5) = 12.04, p < .05). In-depth analysis indicates that the model works well for children (chi 2(5) = 1.80, p > .75), but that observed outcome is significantly better than predicted for infants (chi 2(5) = 17.46, p < .01). Underscoring of children is not the cause of this finding.
CONCLUSIONS: In our center, PRISM scoring overestimates severity of illness in infants. PRISM scoring is not institutionally independent and therefore, at present, a comparison between units may not be justified. A reappraisal of the parameter ranges for infants is suggested.

Entities:  

Mesh:

Year:  1992        PMID: 1458942

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

1.  Calibration of the paediatric index of mortality in UK paediatric intensive care units.

Authors:  G A Pearson; J Stickley; F Shann
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

2.  Risk adjusted mortality of critical illness in a defined geographical region.

Authors:  A J Henderson; L Garland; S Warne; L Bailey; P Weir; S Edees
Journal:  Arch Dis Child       Date:  2002-03       Impact factor: 3.791

Review 3.  Use of risk stratification indices to predict mortality in critically ill children.

Authors:  Maria Grazia Sacco Casamassima; Jose H Salazar; Dominic Papandria; James Fackler; Kristin Chrouser; Emily F Boss; Fizan Abdullah
Journal:  Eur J Pediatr       Date:  2013-03-23       Impact factor: 3.183

4.  Application of the pediatric risk of mortality (PRISM) score and determination of mortality risk factors in a tertiary pediatric intensive care unit.

Authors:  Graziela Araujo Costa; Arthur F Delgado; Alexandre Ferraro; Thelma Suely Okay
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

5.  Sequential Organ Failure Assessment Score As a Predictor of Outcome in Sepsis in Pediatric Intensive Care Unit.

Authors:  A V Lalitha; J K Satish; Mounika Reddy; Santu Ghosh; Jiny George; Chandrakanth Pujari
Journal:  J Pediatr Intensive Care       Date:  2020-07-30

6.  Can generic paediatric mortality scores calculated 4 hours after admission be used as inclusion criteria for clinical trials?

Authors:  Stéphane Leteurtre; Francis Leclerc; Jessica Wirth; Odile Noizet; Eric Magnenant; Ahmed Sadik; Catherine Fourier; Robin Cremer
Journal:  Crit Care       Date:  2004-05-21       Impact factor: 9.097

7.  Predicting mortality in sick African children: the FEAST Paediatric Emergency Triage (PET) Score.

Authors:  Elizabeth C George; A Sarah Walker; Sarah Kiguli; Peter Olupot-Olupot; Robert O Opoka; Charles Engoru; Samuel O Akech; Richard Nyeko; George Mtove; Hugh Reyburn; James A Berkley; Ayub Mpoya; Michael Levin; Jane Crawley; Diana M Gibb; Kathryn Maitland; Abdel G Babiker
Journal:  BMC Med       Date:  2015-07-31       Impact factor: 11.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.